T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients

Journal of Viral Hepatitis

Volumn 22, Issue 12, 2015, Pages 1068-1078

  Wang, Q ^a,b   Sachse, P ^a   Semmo, M ^a   Lokhande, M ^a,c   Montani, M ^a   Dufour, J F ^a,c   Zoulim, F ^d   Klenerman, P ^e   Semmo, N ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF BERN   (Switzerland)

^d CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

anti HBc alone; hepatitis B; memory B cells; T cells

Indexed keywords

CIRCULAR DNA; COVALENTLY CLOSED CIRCULAR DNA; GAMMA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MALE; MEMORY CELL; MIXED INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; B LYMPHOCYTE; BLOOD; CHRONIC HEPATITIS B; IMMUNOLOGY; MIDDLE AGED; SECRETION (PROCESS); VACCINATION; VIROLOGY; VIRUS LOAD;

ADULT; ANTIBODIES, VIRAL; B-LYMPHOCYTES; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; MALE; MIDDLE AGED; T-LYMPHOCYTES; VACCINATION; VIRAL LOAD;

EID: 84945490528     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12428     Document Type: Article

References (29)

1. Dienstag JL,. Hepatitis B virus infection. N Engl J Med 2008; 359 (14): 1486-1500.
2. Berger A, Doerr HW, Rabenau HF, Weber B,. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology 2000; 43 (2): 71-76.
3. Grob P, Jilg W, Bornhak H, et al,. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000; 62 (4): 450-455.
4. Allain JP,. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004; 86 (2): 83-91.
5. Bauer T, Jilg W,. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006; 24 (5): 572-577.
6. Semmo N, Krashias G, Willberg C, Klenerman P,. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection. J Viral Hepatitis 2007; 14 (7): 492-502.
7. Jahnmatz M, Kesa G, Netterlid E, Buisman AM, Thorstensson R, Ahlborg N,. Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses. J Immunol Methods 2013; 391 (1-2): 50-59.
8. Walsh PN, Friedrich DP, Williams JA, et al,. Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials. J Immunol Methods 2013; 394 (1-2): 84-93.
9. Leuridan E, Van Damme P,. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011; 53 (1): 68-75.
10. Hadler SC, Murphy BL, Schable CA, Heyward WL, Francis DP, Kane MA,. Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol 1984; 19 (4): 521-525.
11. Bukhtiari N, Hussain T, Iqbal M, Malik AM, Qureshi AH, Hussain A,. Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc 2003; 53 (4): 136-140.
12. Chaiteerakij R, Komolmit P, Sa-nguanmoo P, Poovorawan Y,. Intrahepatic HBV DNA and covalently closed circular DNA (cccDNA) levels in patients positive for anti-HBc and negative for HBsAg. Southeast Asian J Trop Med Public Health 2010; 41 (4): 867-875.
13. Yuen MF, Wong DK, Fung J, et al,. HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 2008; 135 (4): 1192-1199.
14. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP,. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998; 27 (6): 1736-1742.
15. Yuen MF, Wong DK, Sablon E, et al,. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology 2004; 39 (6): 1694-1701.
16. Abdelmalek MF, Pasha TM, Zein NN, Persing DH, Wiesner RH, Douglas DD,. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure. Liver Transpl 2003; 9 (12): 1253-1257.
17. Zerbini A, Pilli M, Boni C, et al,. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 2008; 134 (5): 1470-1481.
18. Werner JM, Abdalla A, Gara N, Ghany MG, Rehermann B,. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity. Gastroenterology 2013; 145 (5): 1026-1034.
19. Pruss-Ustun A, Rapiti E, Hutin Y,. Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med 2005; 48 (6): 482-490.
20. Hofmann F, Kralj N,. Criteria for successful hepatitis B vaccination in adults: results of a case study. Infection 2009; 37 (3): 266-269.
21. Boot HJ, van der Waaij LA, Schirm J, Kallenberg CG, van Steenbergen J, Wolters B,. Acute hepatitis B in a healthcare worker: a case report of genuine vaccination failure. J Hepatol 2009; 50 (2): 426-431.
22. Bernasconi NL, Traggiai E, Lanzavecchia A,. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002; 298 (5601): 2199-2202.
23. Crotty S, Ahmed R,. Immunological memory in humans. Semin Immunol 2004; 16 (3): 197-203.
24. Williams JL, Christensen CJ, McMahon BJ, et al,. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. Vaccine 2001; 19 (28-29): 4081-4085.
25. Vermeiren AP, Hoebe CJ, Dukers-Muijrers NH,. High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. J Clin Virol 2013; 58 (1): 262-264.
26. Bes M, Esteban JI, Casamitjana N, et al,. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure. Transfusion 2009; 49 (7): 1296-1305.
27. Semmo N, Barnes E, Taylor C, et al,. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet 2005; 365 (9456): 327-329.
28. Hitziger T, Schmidt M, Schottstedt V, et al,. Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity. Transfusion 2009; 49 (7): 1306-1313.
29. Kasprowicz VO, Halliday JS, Mitchell J, Klenerman P,. MIGRAs: are they the new IGRAs? Development of monokine-amplified IFN-gamma release assays. Biomark Med 2012; 6 (2): 177-186.